COMMUNIQUÉS West-GlobeNewswire

Myriad Collaborates with Department of Veterans Affairs in Large Trial Evaluating the GeneSight® Test to Improve Mental Health Outcomes for Veterans
10/11/2017
SALT LAKE CITY, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ: MYGN ), today announced that the Department of Veterans Affairs (VA) recently initiated a [...]
ContraFect to Present at the 2nd Annual Superdrugs and Superbugs USA Conference
10/11/2017
YONKERS, N.Y., Nov. 10, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ: CFRX ), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug- [...]
Deciphera Pharmaceuticals, Inc. Reports Data Analysis from the Ongoing Phase 1 Clinical Trial of DCC-2618 at the Annual Meeting of The Connective Tissue Oncology Society
10/11/2017
- Data Support the Selection of the Recommended Daily Dose of 150 mg - - Durable Disease Control Rates in Heavily Pretreated GIST Patients and Reductions in KIT Mutations Supporting pan-KIT Activity of DCC-2618 Across [...]
Onconova Therapeutics Announces Pricing of Public Offering of Common Stock
10/11/2017
NEWTOWN, Pa., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer [...]
Zomedica Pharmaceuticals Corp. Announces NYSE American Listing Approval
10/11/2017
ANN ARBOR, Mich., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V: ZOM ) ("Zomedica" or the "Company"), a veterinary pharmaceutical and health care solutions company, today announced that the [...]
USPTO approves BioPorto’s NGAL Trauma patent for issuance
10/11/2017
United States Patent and Trademark Office (USPTO) has announced, that BioPorto's NGAL Trauma patent, specifically relating to diagnosing and treating radiation injury, has been approved for issuance. BioPortos’ issued [...]
Herantis Pharma's Manager's Transactions
10/11/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
10/11/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
10/11/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
10/11/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Nine-month interim report (Q3) 2017
10/11/2017
Copenhagen, 2017-11-10 07:30 CET (GLOBE NEWSWIRE) -- Performance for the period (unaudited) (Comparative figures for 2016 are shown in brackets. Revenue growth is measured in local currencies. 2016 comparative figures [...]
MediciNova Appoints Hideki Nagao to its Board of Directors
10/11/2017
LA JOLLA, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
10/11/2017
REGULATED INFORMATION GHENT, Belgium, 10 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Sarepta Therapeutics Announces Exercise of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes Due 2024
10/11/2017
CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
MediciNova Announces Collaboration with the U.S. Department of Veterans Affairs and Oregon Health & Science University to Evaluate MN-166 (ibudilast) in Methamphetamine Use Disorder
10/11/2017
LA JOLLA, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Sucampo to Host 2017 R&D Day on November 16 in New York
09/11/2017
ROCKVILLE, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ: SCMP ), a global biopharmaceutical company, today announced that it will host its 2017 R&D Day for the investment [...]
Dermira to Present at Upcoming Investor Conferences in November
09/11/2017
MENLO PARK, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Myriad Genetics to Present at the 2017 Jefferies London Healthcare Conference
09/11/2017
SALT LAKE CITY, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]
American Health Council Calls for Support to Prevent Closure of Children’s Psychiatric Center
09/11/2017
NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Currently on the state’s closure list, the Western New York Children’s Psychiatric Center (WNYCPC) is facing a possible shutdown with plans for absorption by the Buffalo [...]

Pages